GLP-1 Agonists and Neuroinflammation: Potential in Schizophrenia Treatment | Retatrutide News

A scoping review explores the potential of GLP-1 receptor agonists in treating schizophrenia by modulating neuroinflammation. This highlights a new ther...
Clinical Trials · October 17, 2026